IVF Clinical Trial
Official title:
The Effect of Sildenafil Citrate on the Endometrial Thickness and Pregnancy Rates of Frozen Embryo Transfer Cycles
to investigate the value of adding sildenafil citrate during endometrial preparation in patients undergoing frozen-thawed embryo transfer and its effect on endometrial thickness and pregnancy rates.
Patients who met these conditions entered the study and 110 patients will be divided into two groups 55 patients in each group based on randomized tables. Group 1: will be given estradiol in form of Cycloprogynova white pills starting dose is one pill t.i.d may be increased to two pills t.i.d according to endometrial thickness in day 9 measured by vaginal ultrasound. Group 2: will be given sildenafil citrate tablets (50 mg) daily in addition to the above treatment protocol from the first day of the cycle until the day of starting progesterone. It was discontinued 48- 72 hours prior to the embryo transfer. On the ninth day of the menstrual cycle, the endometrial thickness will be estimated by transvaginal ultrasonography (arranged in a series every other day). The evaluations will be performed by a single investigator. If the endometrial thickness was more than 8mm, 400 mg of progesterone vaginal suppository and Duphastone tabs twice daily will be administered. If the endometrial thickness is less than 8 mm estrogen dosage will be increased to two pills t.i.d and patients would be arranged for follow up every other day for endometrial thickness estimation by transvaginal ultrasound till endometrial thickness is more than 8 mm , then 400 mg of progesterone vaginal suppository and Duphastone tabs twice daily will be administered. Frozen thawed embryo transfer will be carried out after 5 days (blastocyst stage). Estrogen and progesterone will be continued until two weeks after the embryos are transferred. In cases whom BHCG would be positive, estrogen and progesterone will be continued until the 11th week of pregnancy. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05969574 -
Is Decreased Ovarian Reserve Related to an Increased Number of Previous Early Miscarriages?
|
||
Completed |
NCT04778358 -
Higher Dose of Rekovelle in Oocyte Donors
|
Phase 2 | |
Completed |
NCT04052464 -
The Study of the Implantation Window From Endometrial Biopsy With Gene Expression Methods
|
||
Completed |
NCT04108039 -
Micronized Progesterone vs Gonadotropin-releasing Hormone (GnRH) Antagonist in Freeze-all IVF Cycles.
|
N/A | |
Suspended |
NCT04669652 -
Evaluating Piezo-ICSI. - The EPI Study.
|
N/A | |
Completed |
NCT04524026 -
RIOTC: Reducing the Impact of Ovarian Stimulation. Novel Approaches to Luteal Support in IVF-Study 2
|
Phase 2 | |
Recruiting |
NCT05981898 -
Opt-IVF Multi-center Trial 2 Including All Protocols
|
N/A | |
Recruiting |
NCT05737381 -
Quality of Human Embryos in IVF, Culturing in Differentiated Oxygen
|
N/A | |
Recruiting |
NCT04447872 -
The LUTEAL Trial: Luteal Stimulation vs. Estrogen Priming Protocol
|
N/A | |
Completed |
NCT04425317 -
Detection of SARS-CoV-2 in Follicular Fluid and Cumulus-oocyte-complexes in COVID-19 Patients
|
N/A | |
Not yet recruiting |
NCT05932082 -
The Impact of Myomectomy on IVF Outcomes
|
N/A | |
Not yet recruiting |
NCT04283435 -
Endometrial Effects of Sildenafil in Frozen-Thawed Cycles in Women With Thin Endometrium
|
Phase 1 | |
Recruiting |
NCT04654741 -
The Rate of Embryo Euploidy in Progestin-primed Ovarian Stimulation Cycles
|
Phase 4 | |
Completed |
NCT04099784 -
Health of Frozen Transferred Versus Fresh Transferred Children
|
||
Recruiting |
NCT05788822 -
MVA to Improve the Pregnancy Outcome in Aged Infertility Women With Assisted Reproductive Technology
|
N/A | |
Completed |
NCT04956848 -
Comparing KIDScoreā¢ D5 and iDAScore®. The KiDA Study
|
N/A | |
Not yet recruiting |
NCT06048666 -
Platelet Rich Plasma on Ovarian Reserve Parameters and Intra Cytoplasmic Sperm Injection Outcomes in Patients With Diminished Ovarian Reserve
|
Phase 3 | |
Not yet recruiting |
NCT05954962 -
Efficacy of Micronized Natural Progesterone vs GnRH Antagonist in the Prevention of LH Peak During Ovarian Stimulation.
|
Phase 4 | |
Not yet recruiting |
NCT02698488 -
Embryo Selection by Metabolomic Profiling of Embryo Culture Medium With Mass Spectroscopy as an Adjunct to Morphology
|
N/A | |
Completed |
NCT01385618 -
Gene-polymorphisms Relating to Human Subfertility
|
N/A |